Recro Pharma's IPO

Recro Pharma raised a round of funding on March 07, 2014. Investors include Public.

Recro Pharma is a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, initially in the post-operative setting. The company's lead product, an …

Articles about Recro Pharma's IPO: